Search results for abx831170

Solanezumab, Abbexa, abx831170

Solanezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting APP Abeta, soluble monomer, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.